Stock Analysis

Andlauer Healthcare Group President of Specialty Solutions Charles Brogan Sells 35% Of Holding

TSX:AND
Source: Shutterstock

Anyone interested in Andlauer Healthcare Group Inc. (TSE:AND) should probably be aware that the President of Specialty Solutions, Charles Brogan, recently divested CA$211k worth of shares in the company, at an average price of CA$39.63 each. That sale was 35% of their holding, so it does make us raise an eyebrow.

See our latest analysis for Andlauer Healthcare Group

Andlauer Healthcare Group Insider Transactions Over The Last Year

The insider, Ronald Skelton, made the biggest insider sale in the last 12 months. That single transaction was for CA$4.7m worth of shares at a price of CA$39.83 each. So what is clear is that an insider saw fit to sell at around the current price of CA$39.11. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

Over the last year we saw more insider selling of Andlauer Healthcare Group shares, than buying. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
TSX:AND Insider Trading Volume August 23rd 2024

I will like Andlauer Healthcare Group better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

Insider Ownership Of Andlauer Healthcare Group

For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Andlauer Healthcare Group insiders own about CA$22m worth of shares. That equates to 1.4% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The Andlauer Healthcare Group Insider Transactions Indicate?

Unfortunately, there has been more insider selling of Andlauer Healthcare Group stock, than buying, in the last three months. Zooming out, the longer term picture doesn't give us much comfort. Insider ownership isn't particularly high, so this analysis makes us cautious about the company. We're in no rush to buy! So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Andlauer Healthcare Group.

Of course Andlauer Healthcare Group may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.